Zoetis reported $670M in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 3295M 1422M
Aerie Pharmaceuticals AERI:US $ -18.14M 15.51M
Align Technology ALGN:US $ 188.2M 9.89M
Bayer BAYN:GR 169M 4.04B
Bristol Myers Squibb BMY:US $ 2590M 37M
Charles River Laboratories CRL:US $ 187.41M 38.63M
Coherus Biosciences CHRS:US $ -44.01M 43.13M
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Henry Schein HSIC:US $ 220M 24M
Horizon Pharma HZNP:US $ 88.56M 105.76M
Idexx Laboratories IDXX:US $ 179.07M 69.28M
Illumina ILMN:US $ -579000000 763M
IQVIA Holdings Inc IQV:US $ 453M 42M
Johnson & Johnson JNJ:US $ 5840M 22M
Laboratory Of America LH:US $ 525.9M 162M
Lannett LCI:US $ -77.96M 55.88M
Merk MRK:US $ 4927M 642M
Pacira Pharmaceuticals PCRX:US $ 31.24M 13.84M
Patterson Companies PDCO:US $ 34.84M 37.99M
Perrigo Ordinary Shares PRGO:US $ -16.2M 37.9M
Pfizer PFE:US $ 12102M 2229M
Quest Diagnostics DGX:US $ 388M 125M
Teva Pharmaceutical Industries TEVA:US $ -949M 236M
Zoetis ZTS:US $ 670M 57M